Virtus Investment Advisers »

Crispr Therapeutics shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $632k 12k 52.44
2025-09-30 $698k 11k 64.81
2025-06-30 $524k 11k 48.64
2025-03-31 $269k 7.9k 34.03